Gilead Sciences
GILD
#131
Rank
NZ$256.76 B
Marketcap
NZ$206.93
Share price
-1.51%
Change (1 day)
36.87%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): NZ$11.23

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$11.30. In 2024 the company made an earnings per share (EPS) of NZ$0.66 a decrease over its 2023 EPS that were of NZ$7.89.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$11.231604.02%
2024NZ$0.66-91.65%
2023NZ$7.8923.98%
2022NZ$6.36-25.86%
2021NZ$8.584850%
2020NZ$0.17-97.64%
2019NZ$7.350.9%
2018NZ$7.2918.71%
2017NZ$6.14-64.88%
2016NZ$17.48-18.45%
2015NZ$21.4355.28%
2014NZ$13.80296.02%
2013NZ$3.4817.89%
2012NZ$2.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
NZ$22.59 99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$24.84 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.34-79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$7.75-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$19.05 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.98-73.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.10 60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$35.57 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.17 16.47%๐Ÿ‡บ๐Ÿ‡ธ USA